Showing 15 posts of 97 posts found.

Sanofi image

Sanofi and Regeneron post positive alirocumab results

January 9, 2015
Sales and Marketing Regeneron, Sanofi, cholesterol, heart, statin, statins

The latest trials of the potentially blockbuster new heart drug alirocumab show it lowers cholesterol in people at moderate and …

Sanofi image

Sanofi showcases alirocumab at AHA

November 20, 2014
Sales and Marketing Amgen, PCSK9, Regeneron, Sanofi, aha, alirocumab, evolocumab

Sanofi and Regeneron released a battery of new Phase III data on their PCSK9 inhibitor alirocumab this week, reinforcing the …

Amgen image

Amgen submits next gen cholesterol drug

August 29, 2014
Sales and Marketing Amgen, FDA, PCSK9, Regeneron, Sanofi, statins

Amgen has put itself in pole position in the race to market the next generation of injectable statins known as …

Regeneron image

Regeneron to expand manufacturing outside US

March 31, 2014
Manufacturing and Production Ireland, Regeneron, dell, irish. manufacturing

Regeneron is to open its first overseas production facility in Limerick, Ireland, after addressing the initial objections of a national …

Bayer image

Bayer and Regeneron to co-develop wet AMD antibody

January 14, 2014
Research and Development, Sales and Marketing Bayer, Eylea, Regeneron, pdgfr-beta, wet AMD

Bayer and Regeneron are co-developing an antibody to the Platelet Derived Growth Factor Receptor Beta (PDGFR-beta) as a combination therapy …

Regeneron image

Phase III boost for alirocumab

October 17, 2013
Sales and Marketing LDL, Regeneron, alirocumab

Sanofi and Regeneron Pharmaceuticals are celebrating some upbeat data from their investigational treatment alirocumab, which has proved adept at tackling …

Regeneron appoints senior VP from Pfizer

September 11, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pfizer, Regeneron, landry

Regeneron Pharmaceuticals has hired Robert Landry from Pfizer to be its senior vice president and chief financial officer.  Landry will …

Eylea image

NICE green light for Eylea

May 31, 2013
Sales and Marketing Bayer, NICE, Regeneron

NICE has recommended Bayer’s injection Eylea as a treatment for neovascular (wet) age-related macular degeneration (AMD) if the manufacturer offers …

Positive news for Sanofi asthma drug

May 23, 2013
Sales and Marketing Dupilumab, Regeneron, Sanofi, asthma

An asthma drug being developed by Sanofi and Regeneron Pharmaceuticals has performed well in a Phase IIa trial, reducing the …

regeneron image

Sanofi ups stake in Regeneron

February 13, 2013
Sales and Marketing AMD, Regeneron, Sanofi, Zaltrap

Sanofi is increasing its stake in Regeneron Pharmaceuticals by buying shares on the open market and from existing shareholders. The …

Regeneron to invest $70m in NYC manufacturing

November 15, 2012
Manufacturing and Production NY, Regeneron, Sanofi, US

Regeneron has confirmed it will invest almost $70 million to expand its manufacturing in New York City in a move …

Regeneron to expand workforce at New York facility

August 8, 2012
Manufacturing and Production Arcalyst, Eylea, Regeneron, Zaltrap

Buoyant product sales at US biotech Regeneron have prompted the company to undertake a recruitment drive at its manufacturing facility …

Sanofi/Regeneron cholesterol drug reaches Phase III

May 29, 2012
Research and Development, Sales and Marketing Amgen, PCKS9, Regeneron, SAR236553, Sanofi

Sanofi and Regeneron’s anti-cholesterol drug has impressed in a mid-stage trial, and will now progress into Phase III.  The firms’ …

FDA grants priority review for Sanofi cancer drug

April 5, 2012
Research and Development, Sales and Marketing Erbitux, FDA, Regeneron, Sanofi, Zaltrap, colorectal cancer, prostate cancer

The FDA has granted Sanofi and partner Regeneron priority review for their colorectal cancer drug Zaltrap. Zaltrap (aflibercept) is seeking a …

Amgen picture

Sanofi sets up cholesterol drug showdown with Amgen

March 27, 2012
Research and Development, Sales and Marketing Amgen, BMS, LDL, Lipitor, Merck, Regeneron, Sanofi

Sanofi and Amgen have posted results for their new injectable cholesterol drugs within 24 hours of each other.  Both drugs …

Latest content